![(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇结构式](https://www.chemsrc.com/caspic/485/142217-78-5.png)
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇结构式
|
常用名 | (2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇 | 英文名 | 5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanol |
|---|---|---|---|---|
| CAS号 | 142217-78-5 | 分子量 | 823.976 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C52H49N5O5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇 |
|---|---|
| 英文名 | (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol |
| 中文别名 | 恩替卡韦中间体5 | 恩替卡韦中间体五 | 恩替卡韦中间体N5 |
| 英文别名 | 更多 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 分子式 | C52H49N5O5 |
| 分子量 | 823.976 |
| 精确质量 | 823.373352 |
| PSA | 112.78000 |
| LogP | 9.99 |
| 外观性状 | 固体 |
| 折射率 | 1.646 |
| 储存条件 | 2-8°C， 干燥 |
| 危害码 (欧洲) | Xn |
|---|
|
~84%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bisacchi; Chao; Bachard; Daris; Innaimo; Jacobs; Kocy; Lapointe; Martel; Merchant; Slusarchyk; Sundeen; Young; Colonno; Zahler Bioorganic and Medicinal Chemistry Letters, 1997 , vol. 7, # 2 p. 127 - 132 |
|
~%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
|
~%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
|
~%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
|
~%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
|
~%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
|
~%
(2R,3S,5S)-3-苄氧... 142217-78-5 |
| 文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
| (2R,3S,5S)-3-(Benzyloxy)-5-[6-(benzyloxy)-2-{[(4-methoxyphenyl)(diphenyl)methyl]amino}-9H-purin-9-yl]-2-[(benzyloxy)methyl]cyclopentanol |
| Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (2R,3S,5S)- |
| Entecavir-5 |
| Entecavir InterMediate V |
| (1S,3R,4S)-3-(benzyloxy-5-[6-(benzyloxy)-2 -((4-Methoxyphenyl)diphenylMethylaMino) -9H-purin-9-yl]-2-(benzyloxyMethyl)cyclopentanol |
| (2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol |
| (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-Methoxyphenyl)diphenylMethyl)aMino)-9H-purin-9-yl)-2-((benzyloxy)Methyl)cyclopentanol |
| (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9 |
| (1S,2S,3S,5S)-3-(Benzyloxy)-5-[6-(benzyloxy)-2-{[(4-methoxyphenyl)(diphenyl)methyl]amino}-9H-purin-9-yl]-2-[(benzyloxy)methyl]cyclopentanol |
| Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- |
| (1S,2S,3S,5S)-5-(2-((4-Methoxyphenyl)diphenylMethylaMino)-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)Methyl)cyclopentanol |
| Entecavir InterMediate ( # ) |
| Entecavir Impurity 13 |
查看所有供应商和价格请点击：
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇生产厂家
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇价格
![(1S,2R,3S,5R)-3-(苯甲氧基)-2-[(苯甲氧基)甲基]-6-氧杂双环[3.1.0]己烷结构式](https://www.chemsrc.com/caspic/223/110567-22-1.png)
![(1S,2R,3S,5R)-2-[(苄氧甲基)-6-氧杂二环[3.1.0]己-3-醇结构式](https://www.chemsrc.com/caspic/455/117641-39-1.png)
